Difference between revisions of "Team:BostonU/HP/Silver"

Line 385: Line 385:
 
   <p class="inline-heading-type mainwrap">&nbsp;</p>
 
   <p class="inline-heading-type mainwrap">&nbsp;</p>
 
   <p class="inline-heading-type mainwrap">Industry Visits</p>
 
   <p class="inline-heading-type mainwrap">Industry Visits</p>
   <p class="body-type mainwrap">In August, we visited <a href="http://www.ginkgobioworks.com" style="text-indent:0pt;">Ginkgo Bioworks</a> in Boston's Seaport District. We toured their lab facilities, and were impressed by their automated workflow. We were shown some projects relating to synthetic fragrances and toured the workbench of <a href="http://natsaiaudrey.co.uk" style="text-indent:0pt;">Natzai Audrey Chieza</a>, Ginkgo's current artist-in-residence, who uses bacteria to dye fabrics. Afterwards, we had a discussion with Ginkgo's creative director Christina Agapakis about Ginkgo Bioworks' interfaces of art and synthetic biology, and her experiences collaborating with artists and creating topical art herself. Our discussion inspired us to approach art that interfaced with the future of synthetic biology as the mainstay of our human practices project.</p>
+
   <p class="body-type mainwrap">In August, we visited <a href="http://www.ginkgobioworks.com" style="text-indent:0pt;">Ginkgo Bioworks</a> in Boston's Seaport District. We toured their lab facilities, and were impressed by their automated workflow. We were shown some projects relating to synthetic fragrances and toured the workbench of <a href="http://natsaiaudrey.co.uk" style="text-indent:0pt;">Natzai Audrey Chieza</a>, Ginkgo's current artist-in-residence, who uses bacteria to dye fabrics. Afterwards, we had a discussion with Ginkgo's creative director <a href="http://agapakis.com/">Christina Agapakis</a> about Ginkgo Bioworks' interfaces of art and synthetic biology, and her experiences collaborating with artists and creating topical art herself. Our discussion inspired us to approach art that interfaced with the future of synthetic biology as the mainstay of our human practices project.</p>
 
<br>
 
<br>
 
   <p class="body-type mainwrap">We also visited the <a href="http://www.cse.fraunhofer.org" style="text-indent:0pt;">Fraunhofer Center for Manufacturing Innovation</a> with BostonU_Hardware to inform our collaboration towards a microfluidic platform for RNA detection. They provided us with a wealth of knowledge about the considerations needed to translate a biological protocol to a microfluidic device at scale. More information about this collaboration can be found <a href="https://2017.igem.org/Team:BostonU/Collaborations" style="text-indent:0pt;">here</a>.</p>
 
   <p class="body-type mainwrap">We also visited the <a href="http://www.cse.fraunhofer.org" style="text-indent:0pt;">Fraunhofer Center for Manufacturing Innovation</a> with BostonU_Hardware to inform our collaboration towards a microfluidic platform for RNA detection. They provided us with a wealth of knowledge about the considerations needed to translate a biological protocol to a microfluidic device at scale. More information about this collaboration can be found <a href="https://2017.igem.org/Team:BostonU/Collaborations" style="text-indent:0pt;">here</a>.</p>

Revision as of 16:57, 1 November 2017

HUMAN PRACTICES